Recommendations for aortopathies, cardiac surgery, and pregnancy — Recommendation Table 8
Beta-blocker therapy throughout pregnancy and in the post-partum period is recommended in women with MFS and other HTADs. Guideline rec
Class ILevel CRevised from 2018Rec Table 8 · §8 · p.4503
What changed from 2018
2018 (IIa, C): Beta-blocker therapy throughout pregnancy should be considered in women with Marfan syndrome and other heritable thoracic aortic diseases.
Educational summary of the 2025 ESC Guidelines. It does not replace clinical judgement or local protocol.
Pending physician review: this page has not yet been signed off by a named reviewer. · Reviewer: — (placeholder) · Reviewed: — ·
Content version 0.1.0-draft · 2025 ESC Guidelines (Eur Heart J 2025;46:4462–4568)